» Articles » PMID: 36302803

Impact of Kidney Function and Kidney Volume on Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease

Overview
Journal Sci Rep
Specialty Science
Date 2022 Oct 27
PMID 36302803
Authors
Affiliations
Soon will be listed here.
Abstract

Presently, only personal or family history of intracranial aneurysm/subarachnoid hemorrhage (IA/SAH) has been established as a risk factor for IA in autosomal dominant polycystic kidney disease (ADPKD). This study aimed to verify the association between kidney function/volume and IAs in patients with ADPKD. This study included 519 patients with ADPKD. At baseline IA screening, the median age and estimated glomerular filtration rate were 44 years and 54.5 mL/min/1.73 m, respectively. Family IA/SAH history was confirmed in 18.1% of the patients, and 54.3% of the patients had hypertension. The IA point prevalence was 12.5%. During clinical follow up of 3104 patient-years, de novo IA was detected in 29 patients (0.93% patient-years). The IA period prevalence was 18.1% (median age, 60 years). Multivariable logistic regression demonstrated that total kidney volume (TKV) ≥ 1000 mL (odds ratio [OR] = 2.81), height-adjusted TKV ≥ 500 mL (OR = 2.81), Mayo imaging classification Class 1D-1E (OR = 2.52), and chronic kidney disease stages 3-5 (OR = 2.31) were significantly associated with IA formation. IAs in patients with ADPKD may be associated not only with general risk factors for IAs but also with declining kidney function and increased KV. Kidney disease progression may contribute to effective IA screening and treatment planning in patients with ADPKD.

Citing Articles

Patients' Characteristics Associated With Size of Ruptured and Unruptured Intracranial Aneurysms.

Dinger T, Chihi M, Gumus M, Riess C, Santos A, Moskopp M Brain Behav. 2024; 14(11):e70161.

PMID: 39607092 PMC: 11603431. DOI: 10.1002/brb3.70161.


Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease.

Nitta K, Kataoka H, Manabe S, Makabe S, Akihisa T, Ushio Y Clin Exp Nephrol. 2024; 29(1):75-82.

PMID: 39322826 DOI: 10.1007/s10157-024-02568-6.


Data driven approach to characterize rapid decline in autosomal dominant polycystic kidney disease.

Sim J, Shu Y, Bhandari S, Chen Q, Harrison T, Lee M PLoS One. 2024; 19(6):e0298484.

PMID: 38837988 PMC: 11152279. DOI: 10.1371/journal.pone.0298484.


Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease.

Ushio Y, Kataoka H, Akagawa H, Sato M, Manabe S, Kawachi K J Nephrol. 2024; 37(4):983-992.

PMID: 38315279 DOI: 10.1007/s40620-023-01866-8.


Cardiovascular Manifestations and Management in ADPKD.

Sagar P, Rangan G Kidney Int Rep. 2023; 8(10):1924-1940.

PMID: 37850017 PMC: 10577330. DOI: 10.1016/j.ekir.2023.07.017.


References
1.
Sanchis I, Shukoor S, Irazabal M, Madsen C, Chebib F, Hogan M . Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2019; 14(8):1151-1160. PMC: 6682820. DOI: 10.2215/CJN.14691218. View

2.
Dong K, Zhang C, Tian X, Coman D, Hyder F, Ma M . Renal plasticity revealed through reversal of polycystic kidney disease in mice. Nat Genet. 2021; 53(12):1649-1663. PMC: 9278957. DOI: 10.1038/s41588-021-00946-4. View

3.
Schievink W, Torres V, Piepgras D, Wiebers D . Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1992; 3(1):88-95. DOI: 10.1681/ASN.V3188. View

4.
Flahault A, Joly D . Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2019; 14(8):1242-1244. PMC: 6682822. DOI: 10.2215/CJN.02100219. View

5.
Kataoka H, Yoshida R, Iwasa N, Sato M, Manabe S, Kawachi K . Germline Mutations for Kidney Volume in ADPKD. Kidney Int Rep. 2022; 7(3):537-546. PMC: 8897295. DOI: 10.1016/j.ekir.2021.12.012. View